Asia Pacific Covid-19 Diagnostics Market Size & Outlook
Asia Pacific covid-19 diagnostics market, 2020-2030 (US$M)
Related Markets
Asia Pacific covid-19 diagnostics market highlights
- The Asia Pacific covid-19 diagnostics market generated a revenue of USD 9,818.5 million in 2023.
- The market is expected to grow at a CAGR of -24.8% from 2024 to 2030.
- In terms of segment, reagents & kits was the largest revenue generating product in 2023.
- Reagents & Kits is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Australia is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 9,818.5 million |
| Market revenue in 2030 | USD 1,333.4 million |
| Growth rate | -24.8% (CAGR from 2023 to 2030) |
| Largest segment | Reagents & kits |
| Fastest growing segment | Reagents & Kits |
| Historical data covered | 2020 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents & Kits, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, Hologic Inc, Roche, PerkinElmer, Veredus Laboratories, QuidelOrtho Corp, Quest Diagnostics Inc, Luminex, Labcorp Holdings Inc, Abbott Laboratories, 1Drop Diagnostics, ADT Inc, Mylab Discovery Solutions, Neuberg Diagnostics, Aldatu Biosciences, altona Diagnostics GmbH |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 29.7% of the global covid-19 diagnostics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Latin America is the fastest growing regional market and is projected to reach USD 282.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
COVID-19 Diagnostics Market Scope
COVID-19 Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific covid-19 diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to covid-19 diagnostics market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 67.46% in 2023. Horizon Databook has segmented the Asia Pacific covid-19 diagnostics market based on instruments, reagents & kits, services covering the revenue growth of each sub-segment from 2020 to 2030.
Asia Pacific witnessed a significant growth in the global market. The increasing pool of local diagnostic kits & reagents manufacturers providing testing solutions for COVID-19 detection contributed to revenue generation in the region.
Furthermore, collaborations between countries are expected to boost the adoption of COVID-19 diagnostic products in the region. Along with this, many companies in the region have entered into partnerships with international companies for developing and manufacturing COVID-19 diagnostic tests.
In May 2020, Duke-NUS Medical School from Singapore collaborated with Diagnostics Development Hub & Gen Script Biotech for the developing as well as manufacturing a COVID-19 detection system. Asia Pacific countries were able to manage the COVID-19 crisis.
Reasons to subscribe to Asia Pacific covid-19 diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific covid-19 diagnostics market databook
-
Our clientele includes a mix of covid-19 diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific covid-19 diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific covid-19 diagnostics market from 2020 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific covid-19 diagnostics market size, by country, 2020-2030 (US$M)
Asia Pacific COVID-19 Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
